Healthcare -
Biotechnology - NASDAQ - US
$ 0.6601
-5.47 %
$ 83.3 M
Market Cap
-0.63
P/E
Price Target
Average
899.85%
Revenue Forecast
Estimate
26.81%
EBIT
Estimate
--24.24%
Net Income
Estimate
59.21%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Karyopharm Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for KPTI of $6.6 , with forecasts ranging from
a
low of
$3 to a high of $14 .
KPTI Lowest Price Target
Wall Street Target
3 USD
354.48%
KPTI Average Price Target
Wall Street Target
6.6 USD
899.85%
KPTI Highest Price Target
Wall Street Target
14 USD
2020.89%
REVENUE FORECAST
Revenue Forecast Chart KPTI
EBIT FORECAST
EBIT Forecast Chart KPTI
NET INCOME FORECAST
Net Income Chart KPTI